🇺🇸 FDA
Pipeline program

Co-Trimoxazole 960Mg Dispersible Tablet

17/0894

Phase 3 small_molecule active

Quick answer

Co-Trimoxazole 960Mg Dispersible Tablet for Spontaneous Bacterial Peritonitis is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Spontaneous Bacterial Peritonitis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials